跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 7,552 条关于
“Durasert E”
全部
7,552
临床试验
2,505
药物
958
机构
3,068
资讯
1,021
2年前
EYP-1901 Shows Promise in Reducing Treatment Burden for Wet AMD Patients in Phase 2 DAVIO-2 Trial
去年
EyePoint Pharmaceuticals Doses First Patient in Phase 3 LUGANO Trial of Duravyu for Wet AMD
11个月前
EyePoint Pharmaceuticals Raises $150 Million to Advance DURAVYU Phase 3 Trials for Retinal Diseases
去年
EyePoint Pharmaceuticals Doses First Patient in Phase 3 Trial of Duravyu for Wet AMD
去年
EyePoint's DURAVYU Shows Promising Results in Phase 2 DME Trial with Extended Treatment Duration
去年
EYP-1901 Shows Promise in Wet AMD and DME Trials with Significant Reduction in Treatment Burden
去年
EyePoint's EYP-1901 Shows Non-Inferiority to Aflibercept in Wet AMD
去年
EyePoint's DURAVYU Shows Promise in Phase 2 DME Trial
去年
EyePoint's Duravyu Shows Promise in Phase 2 Trial for Diabetic Macular Edema
去年
EyePoint's DURAVYU Enters Phase 3 Trial for Wet AMD with First Patient Dosed in LUCIA Study
第 1 页,共 103 页
上一页
下一页